Scinai Immunotherapeutics (SCNI) Other Operating Expenses (2019 - 2024)

Scinai Immunotherapeutics has disclosed Other Operating Expenses across 5 years of filings, most recently posting -$2.8 million for Q3 2024.

• Other Operating Expenses for Q3 2024 came in at -$2.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.8 million (changed 0.0% YoY), and the FY2025 annual result was $39000.0, changed N/A from the prior year.
• Other Operating Expenses came in at -$2.8 million for Q3 2024 at Scinai Immunotherapeutics, down from $124000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $35.7 million in Q3 2020 to a low of -$9.6 million in Q2 2020.
• The 4-year median for Other Operating Expenses is $124000.0 (2024), against an average of $5.7 million.
• Peak annual rise in Other Operating Expenses reached 194.39% in 2020, while the deepest fall reached 194.39% in 2020.
• Scinai Immunotherapeutics' Other Operating Expenses stood at $35.7 million in 2020, then plunged by 78.95% to $7.5 million in 2022, then increased by 21.8% to $9.2 million in 2023, then slumped by 130.73% to -$2.8 million in 2024.
• The last three Other Operating Expenses figures came in at -$2.8 million (Q3 2024), $124000.0 (Q2 2024), and -$124000.0 (Q1 2024), per Business Quant data.